EZR and colorectal cancer: Hypoxia, for instance, plays a well-known role in cancer progression as well as treatment resistance (reviewed in ref. 36); and enhanced ezrin activity has been observed within hypoxic regions of colorectal cancers containing tumor-initiating cells (37).